Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lornoxicam in Mild to Moderate Alzheimer's Disease
NCT01117948Phase 2Terminated
- Sponsor
- JSW LifeSciences
- Start
- Sep 2009
- Primary completion
- Apr 2011
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of lornoxicam in Alzheimer's disease (AD), sponsored by JSW LifeSciences. Started Sep 2009; status: terminated.
02
Drugs
lornoxicam
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT01117948.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01117948.